Sodium-glucose co-transporter-2 inhibitors and sacubitril/valsartan combination in patients with heart failure with reduced ejection fraction; does it deserve our attention?

被引：5
|
作者：
Patoulias, Dimitrios [1 ]
Papadopoulos, Christodoulos [2 ]
Doumas, Michael [1 ,3 ]
机构：
[1] Aristotle Univ Thessaloniki, Gen Hosp Hippokrat, Propedeut Dept Internal Med 2, Thessaloniki, Greece
[2] Aristotle Univ Thessaloniki, Gen Hosp Hippokrat, Dept Cardiol 3, Thessaloniki, Greece
[3] George Washington Univ, Vet Affairs Med Ctr, Washington, DC USA
来源：
AMERICAN HEART JOURNAL | 2021年 / 236卷
关键词：
D O I：
10.1016/j.ahj.2021.02.006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：104 / 105
页数：2
相关论文
共 50 条
  • [41] Pharmacological mechanisms of sodium-glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction
    Liang, Bo
    Liang, Yi
    Gu, Ning
    BMC CARDIOVASCULAR DISORDERS, 2022, 22 (01)
  • [42] Sacubitril/Valsartan in Asian Patients with Heart Failure with Reduced Ejection Fraction
    Dewan, Pooja
    Docherty, Kieran F.
    McMurray, John J., V
    KOREAN CIRCULATION JOURNAL, 2019, 49 (06) : 469 - 484
  • [43] What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?
    Muhammad Shahzeb Khan
    Muthiah Vaduganathan
    Current Diabetes Reports, 2020, 20
  • [44] What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?
    Khan, Muhammad Shahzeb
    Vaduganathan, Muthiah
    CURRENT DIABETES REPORTS, 2020, 20 (11)
  • [45] Sodium-glucose co-transporter-2 inhibitors in the non-diabetic heart failure patient
    Essa, Hani
    Walker, Lauren
    Sankaranarayanan, Rajiv
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (06) : 2566 - 2570
  • [46] SACUBITRIL VALSARTAN IN AGED PATIENTS AND HEART FAILURE WITH REDUCED EJECTION FRACTION: DOES IT REALLY WORK?
    Romero, Jose Maria
    Garcia, Marcelino Cortes
    Nieto-Roca, Luis
    German, Jorge Balaguer
    Chapel, Jose Antonio Esteban
    Urquia, Mikel Taibo
    Pello, Ana Maria
    Lopez, Carlos Rodriguez
    Tunon, Jose
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 544 - 544
  • [47] META-ANALYSIS EVALUATING THE EFFICACY OF SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITORS IN SUBJECTS WITH HEART FAILURE WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION
    Patoulias, Dimitrios
    Katsimardou, Alexandra
    Toumpourleka, Maria
    Zografou, Ioanna
    Petidis, Konstantinos
    Imprialos, Konstantinos
    Kassimis, George
    Boulmpou, Aristi
    Papadopoulos, Christodoulos
    Doumas, Michael
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL 1) : E69 - E70
  • [48] META-ANALYSIS EVALUATING THE EFFICACY OF SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITORS IN SUBJECTS WITH HEART FAILURE WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION
    Patoulias, Dimitrios
    Katsimardou, Alexandra
    Toumpourleka, Maria
    Zografou, Ioanna
    Petidis, Konstantinos
    Imprialos, Konstantinos
    Kassimis, George
    Boulmpou, Aristi
    Papadopoulos, Christodoulos
    Doumas, Michael
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL) : E69 - E70
  • [49] Eligibility of sodium-glucose co-transporter-2 inhibitors among patients with diabetes mellitus admitted for heart failure
    Sharma, Abhinav
    Wu, Jingjing
    Ezekowitz, Justin A.
    Felker, Gary Michael
    Udell, Jacob A.
    Heidenreich, Paul A.
    Fonarow, Gregg C.
    Mahaffey, Kenneth W.
    Hernandez, Adrian F.
    DeVore, Adam D.
    ESC HEART FAILURE, 2020, 7 (01): : 275 - 279
  • [50] Impact of sodium glucose co-transporter-2 inhibitors on left atrial functions in patients with type-2 diabetes and heart failure with mildly reduced ejection fraction
    El-Saied, Shaimaa B.
    El-Sherbeny, Wafaa S.
    El-sharkawy, Sara I.
    IJC HEART & VASCULATURE, 2024, 50
12345